Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20194844

J. Clin. Oncol. 2010 Apr 1 28 10 1756-65

Download in:

View as

Triples

General Info

PMID
20194844